Comparing Structure-Based & Sequence-Based De Novo Design to Improve Precision & Scalability
Time: 9:00 am
day: Conference Day Two
Details:
- Contrast the strengths of structure-based design (precision, epitope targeting) with the speed and scalability of sequence-based approaches
- Examine case studies highlighting how each approach performs across antigen diversity and design complexity
- Identify hybrid strategies that combine both approaches to balance early exploration with therapeutic relevance
NEW COMPANY!
